Drug Manufacturer Interest In Rx-To-OTC Pipeline Growing – FDA’s Ganley
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeing increased activity from drug companies wanting to switch their prescription drug products over-the-counter, according to Center for Drug Evaluation & Research OTC Drug Products Division Director Charles Ganley, MD